Primary Site >> Liver Cancer

Gene >> HLF

Journal: Int J Cancer. 1996 Sep 17;67(6):892-7.
Title: Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes.
Author: Uchida, T|Takahashi, K|Tatsuno, K|Dhingra, U|Eliason, J F
PMID: 8824564
Journal: J Gen Virol. 1999 Dec;80 ( Pt 12):3257-65.
Title: Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system.
Author: Shintani, Y|Yotsuyanagi, H|Moriya, K|Fujie, H|Tsutsumi, T|Kanegae, Y|Kimura, S|Saito, I|Koike, K
PMID: 10567659
Journal: Hepatol Res. 2001 May 1;20(1):84-96.
Title: Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use.
Author: Matsumura, M|Ijichi, M|Shiratori, Y|Togo, G|Hikiba, Y|Inoued, K|Kohara, M|Omata, M
PMID: 11282488
Journal: Cancer Res. 2003 Oct 1;63(19):6282-9.
Title: Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
Author: Noda, Katsuhisa|Miyoshi, Eiji|Gu, Jianguo|Gao, Cong-Xiao|Nakahara, Susumu|Kitada, Takatoshi|Honke, Koichi|Suzuki, Kunio|Yoshihara, Harumasa|Yoshikawa, Kiyoshi|Kawano, Kiyoshi|Tonetti, Michela|Kasahara, Akinori|Hori, Masatsugu|Hayashi, Norio|Taniguchi, Nao
PMID: 14559815
Journal: Int J Oncol. 2006 Dec;29(6):1501-8.
Title: Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
Author: Matsumoto, Kazuya|Okano, Jun-Ichi|Nagahara, Takakazu|Murawaki, Yoshikazu
PMID: 17088989
Journal: Oncol Rep. 2008 Oct;20(4):863-72.
Title: The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.
Author: Matsumoto, Kazuya|Nagahara, Takakazu|Okano, Jun-Ichi|Murawaki, Yoshikazu
PMID: 18813828
Journal: BMC Cancer. 2009 Jul 18;9:240.
Title: Twist expression promotes migration and invasion in hepatocellular carcinoma.
Author: Matsuo, Noriyuki|Shiraha, Hidenori|Fujikawa, Tatsuya|Takaoka, Nobuyuki|Ueda, Naoki|Tanaka, Shigetomi|Nishina, Shinichi|Nakanishi, Yutaka|Uemura, Masayuki|Takaki, Akinobu|Nakamura, Shinichiro|Kobayashi, Yoshiyuki|Nouso, Kazuhiro|Yagi, Takahito|Yamamoto, Ka
PMID: 19615090
Journal: Exp Ther Med. 2011 May;2(3):399-403.
Title: Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma.
Author: Liu, Shi|Gong, Jian|Morishita, Asahiro|Nomura, Takako|Miyoshi, Hisaaki|Tani, Joji|Kato, Kiyohito|Yoneyama, Hirohito|Deguchi, Akihiro|Mori, Hirohito|Mimura, Shima|Nomura, Kei|Himoto, Takashi|Deguchi, Kazushi|Okano, Keiichi|Izuishi, Kunihiko|Suzuki, Yasuyuk
PMID: 22977516
Journal: Oncol Lett. 2012 May;3(5):1047-1051.
Title: The expression levels of CD44v6 are correlated with the invasiveness of hepatocellular carcinoma in vitro, but do not appear to be clinically significant.
Author: Mima, Kosuke|Okabe, Hirohisa|Ishimoto, Takatsugu|Hayashi, Hiromitsu|Nakagawa, Shigeki|Kuroki, Hideyuki|Miyake, Keisuke|Takamori, Hiroshi|Beppu, Toru|Baba, Hideo
PMID: 22783389
Journal: Biol Pharm Bull. 2012;35(3):400-7.
Title: Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.
Author: Kawano, Yohei|Nagata, Masashi|Kohno, Takafumi|Ichimiya, Akihiro|Iwakiri, Tomomi|Okumura, Manabu|Arimori, Kazuhiko
PMID: 22382328
Journal: Pathobiology. 2012;79(3):115-26.
Title: Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
Author: Wilkens, Ludwig|Hammer, Caroline|Glombitza, Sabine|Muller, Dominique-Elisabeth
PMID: 22261732
Journal: J Gastroenterol. 2013 Jun;48(6):738-50.
Title: Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis.
Author: Saeki, Issei|Terai, Shuji|Fujisawa, Koichi|Takami, Taro|Yamamoto, Naoki|Matsumoto, Toshihiko|Hirose, Yoshikazu|Murata, Yasuhiko|Yamasaki, Takahiro|Sakaida, Isao
PMID: 23011081
Journal: Oncol Rep. 2013 Nov;30(5):2476-80.
Title: Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.
Author: Nomura, Takako|Morishita, Asahiro|Jian, Gong|Mimura, Shima|Kato, Kiyohito|Nomura, Kei|Tani, Joji|Miyoshi, Hisaaki|Yoneyama, Hirohito|Sakamoto, Teppei|Fujita, Koji|Maeda, Emiko|Kobara, Hideki|Mori, Hirohito|Iwama, Hisakazu|Masaki, Tsutomu
PMID: 23970062
Journal: Cancer Res. 2014 Nov 1;74(21):5963-77.
Title: Network modeling of TGFbeta signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation.
Author: Steinway, Steven Nathaniel|Zanudo, Jorge G T|Ding, Wei|Rountree, Carl Bart|Feith, David J|Loughran, Thomas P Jr|Albert, Reka
PMID: 25189528
Journal: Biomed Rep. 2014 Nov;2(6):799-803.
Title: Co-culture of hepatocellular carcinoma cells and human umbilical endothelial cells damaged by SU11274.
Author: Tomizawa, Minoru|Shinozaki, Fuminobu|Motoyoshi, Yasufumi|Sugiyama, Takao|Yamamoto, Shigenori|Ishige, Naoki
PMID: 25279148
Journal: Oncol Lett. 2014 Nov;8(5):2023-2026.
Title: Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.
Author: Tomizawa, Minoru|Shinozaki, Fuminobu|Motoyoshi, Yasufumi|Sugiyama, Takao|Yamamoto, Shigenori|Sueishi, Makoto
PMID: 25289088
Journal: Clin Epigenetics. 2015 Sep 11;7:98.
Title: Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma.
Author: Sajadian, Sahar Olsadat|Ehnert, Sabrina|Vakilian, Haghighat|Koutsouraki, Eirini|Damm, Georg|Seehofer, Daniel|Thasler, Wolfgang|Dooley, Steven|Baharvand, Hossein|Sipos, Bence|Nussler, Andreas K
PMID: 26366235
Journal: Br J Cancer. 2015 Jul 14;113(2):252-8.
Title: miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells.
Author: Higashi, T|Hayashi, H|Ishimoto, T|Takeyama, H|Kaida, T|Arima, K|Taki, K|Sakamoto, K|Kuroki, H|Okabe, H|Nitta, H|Hashimoto, D|Chikamoto, A|Beppu, T|Baba, H
PMID: 26125451
Journal: Int J Oncol. 2015 Aug;47(2):535-42.
Title: MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Author: Miyata, Miwa|Morishita, Asahiro|Sakamoto, Teppei|Katsura, Akiko|Kato, Kiyohito|Nishioka, Tomoko|Toyota, Yuka|Fujita, Koji|Maeda, Emiko|Nomura, Takako|Tani, Joji|Miyoshi, Hisaaki|Yoneyama, Hirohito|Kobara, Hideki|Fujiwara, Shintaro|Nishiyama, Noriko|Iwama,
PMID: 26060089
Journal: Cancer Sci. 2015 May;106(5):567-75.
Title: Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib.
Author: Ishijima, Naoki|Kanki, Keita|Shimizu, Hiroki|Shiota, Goshi
PMID: 25683251
Journal: Clin Sci (Lond). 2015 Jun;128(11):761-74.
Title: Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
Author: Feng, Teng|Dzieran, Johanna|Gu, Xing|Marhenke, Silke|Vogel, Arndt|Machida, Keigo|Weiss, Thomas S|Ruemmele, Petra|Kollmar, Otto|Hoffmann, Patrick|Grasser, Friedrich|Allgayer, Heike|Fabian, Jasmin|Weng, Hong Lei|Teufel, Andreas|Maass, Thorsten|Meyer, Christ
PMID: 25602745
Journal: BMC Cancer. 2015 Apr 11;15:260.
Title: Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
Author: Yamada, Takeshi|Abei, Masato|Danjoh, Inaho|Shirota, Ryoko|Yamashita, Taro|Hyodo, Ichinosuke|Nakamura, Yukio
PMID: 25885470
Journal: Int J Oncol. 2016 May;48(5):1794-804.
Title: Hepatocellular carcinoma cell sensitivity to Vgamma9Vdelta2 T lymphocyte-mediated killing is increased by zoledronate.
Author: Sugai, Shiori|Yoshikawa, Toshiaki|Iwama, Tatsuaki|Tsuchiya, Nobuhiro|Ueda, Norihiro|Fujinami, Norihiro|Shimomura, Manami|Zhang, Rong|Kaneko, Shin|Uemura, Yasushi|Nakatsura, Tetsuya
PMID: 26936487
Journal: Cancer Lett. 2016 Jun 28;376(1):188-96.
Title: An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Author: Leng, Chao|Zhang, Zhan-Guo|Chen, Wei-Xun|Luo, Hong-Ping|Song, Jia|Dong, Wei|Zhu, Xuan-Ru|Chen, Xiao-Ping|Liang, Hui-Fang|Zhang, Bi-Xiang
PMID: 26996299
Journal: Biochem Biophys Res Commun. 2016 Aug 5;476(4):501-507.
Title: A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines.
Author: Toki, Yasumichi|Sasaki, Katsunori|Tanaka, Hiroki|Yamamoto, Masayo|Hatayama, Mayumi|Ito, Satoshi|Ikuta, Katsuya|Shindo, Motohiro|Hasebe, Takumu|Nakajima, Shunsuke|Sawada, Koji|Fujiya, Mikihiro|Torimoto, Yoshihiro|Ohtake, Takaaki|Kohgo, Yutaka
PMID: 27264950
Journal: Eur J Med Res. 2016 Jun 24;21(1):26.
Title: HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Author: Buurman, Reena|Sandbothe, Maria|Schlegelberger, Brigitte|Skawran, Britta
PMID: 27342975
Journal: Oncol Lett. 2016 Sep;12(3):1687-1692.
Title: MicroRNA profiles in various hepatocellular carcinoma cell lines.
Author: Morishita, Asahiro|Iwama, Hisakazu|Fujihara, Shintaro|Sakamoto, Teppei|Fujita, Koji|Tani, Joji|Miyoshi, Hisaaki|Yoneyama, Hirohito|Himoto, Takashi|Masaki, Tsutomu
PMID: 27588118
Journal: Cell Signal. 2016 Dec;28(12):1872-1880.
Title: Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP).
Author: Tran, Doan Duy Hai|Koch, Alexandra|Allister, Aldrige|Saran, Shashank|Ewald, Florian|Koch, Martina|Nashan, Bjorn|Tamura, Teruko
PMID: 27619201
Journal: J Gastroenterol Hepatol. 2017 Oct;32(10):1769-1777.
Title: Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Author: Sawahara, Hiroaki|Shiraha, Hidenori|Uchida, Daisuke|Kato, Hironari|Kato, Ryo|Oyama, Atsushi|Nagahara, Teruya|Iwamuro, Masaya|Horiguchi, Shigeru|Tsutsumi, Koichiro|Mandai, Mari|Mimura, Tetsushige|Wada, Nozomu|Takeuchi, Yasuto|Kuwaki, Kenji|Onishi, Hideki|N
PMID: 28168749
Journal: Cancer Cell Int. 2017 Oct 23;17:94.
Title: Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma.
Author: Hayashi, Takehiro|Yamashita, Taro|Okada, Hikari|Nio, Kouki|Hara, Yasumasa|Nomura, Yoshimoto|Hayashi, Tomoyuki|Asahina, Yoshiro|Yoshida, Mariko|Oishi, Naoki|Sunagozaka, Hajime|Takatori, Hajime|Honda, Masao|Kaneko, Shuichi
PMID: 29075151
Journal: Oncol Lett. 2017 Jul;14(1):899-902.
Title: Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for alpha-fetoprotein and CD44.
Author: Tomizawa, Minoru|Shinozaki, Fuminobu|Motoyoshi, Yasufumi|Sugiyama, Takao|Yamamoto, Shigenori|Ishige, Naoki
PMID: 28693249
Journal: Oncol Lett. 2017 Mar;13(3):1264-1268.
Title: Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine.
Author: Tomizawa, Minoru|Shinozaki, Fuminobu|Motoyoshi, Yasufumi|Sugiyama, Takao|Yamamoto, Shigenori|Ishige, Naoki
PMID: 28454244
Journal: Oncol Lett. 2017 Feb;13(2):800-804.
Title: 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.
Author: Tomizawa, Minoru|Shinozaki, Fuminobu|Motoyoshi, Yasufumi|Sugiyama, Takao|Yamamoto, Shigenori|Ishige, Naoki
PMID: 28356961
Journal: Oncol Rep. 2018 Feb;39(2):843-850.
Title: Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Author: Yokoi, Kenta|Kobayashi, Akira|Motoyama, Hiroaki|Kitazawa, Masato|Shimizu, Akira|Notake, Tsuyoshi|Yokoyama, Takahide|Matsumura, Tomio|Takeoka, Michiko|Miyagawa, Shin-Ichi
PMID: 29251327
Journal: Int J Mol Sci. 2018 Mar 6;19(3). pii: ijms19030748.
Title: Polymeric Nano-Micelles as Novel Cargo-Carriers for LY2157299 Liver Cancer Cells Delivery.
Author: Hanafy, Nemany Abdelhamid Nemany|Quarta, Alessandra|Ferraro, Marzia Maria|Dini, Luciana|Nobile, Concetta|De Giorgi, Maria Luisa|Carallo, Sonia|Citti, Cinzia|Gaballo, Antonio|Cannazza, Giuseppe|Rinaldi, Rosaria|Giannelli, Gianluigi|Leporatti, Stefano
PMID: 29509706
Journal: Cell Death Dis. 2018 Mar 7;9(3):373.
Title: Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.
Author: Rani, Bhavna|Malfettone, Andrea|Dituri, Francesco|Soukupova, Jitka|Lupo, Luigi|Mancarella, Serena|Fabregat, Isabel|Giannelli, Gianluigi
PMID: 29515105
Journal: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018 May;34(5):427-433.
Title: [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells].
Author: Dai, Jimin|Niu, Kunwei|Wang, Bo|Li, Yijie|Xia, Congcong|Tao, Kaishan|Dai, Jingyao
PMID: 30043734
Journal: J Exp Clin Cancer Res. 2018 Sep 3;37(1):211.
Title: Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours.
Author: Nwosu, Zeribe C|Battello, Nadia|Rothley, Melanie|Pioronska, Weronika|Sitek, Barbara|Ebert, Matthias P|Hofmann, Ute|Sleeman, Jonathan|Wolfl, Stefan|Meyer, Christoph|Megger, Dominik A|Dooley, Steven
PMID: 30176945